Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects

Clinical trial NCT04030559 · TERMINATED

Trial details

NCT number: NCT04030559
Sponsor: University of California, Davis
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

ATM Gene Mutation BRCA1 Gene Mutation BRCA2 Gene Mutation BRIP1 Gene Mutation CDK12 Gene Mutation CHEK1 Gene Mutation CHEK2 Gene Mutation DNA Damage Response Gene Mutation DNA Repair Gene Mutation FANCA Gene Mutation FANCD2 Gene Mutation FANCL Gene Mutation

Start date: 2020-02-25
Primary completion: 2024-01-10
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.